1 December, 2017

INCLASS

2023-01-09T12:15:00+03:00By |Categories: Completed, Interventional, Sepsis and severe infections, Studies|Tags: , |

Completed study Official Study Title A double-blind, randomized, placebo-controlled clinical study of the efficacy of INtravenous CLArithromycin as adjunctive treatment in patients with Sepsis and respiratory and multiple organ dysfunction Syndrome Brief Description INCLASS is a randomized clinical trial aiming to compare the efficacy of intravenous clarithromycin over placebo in patients with sepsis and

23 May, 2016

Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis

2023-02-16T15:31:14+03:00By |Categories: Other Grants, Publications|Tags: , |

Thomas Tsaganos, Maria Raftogiannis, Maria Pratikaki, Sofia Christodoulou, Anastasia Kotanidou, Evangelos Papadomichelakis, Apostolos Armaganidis, Christina Routsi, Evangelos J. Giamarellos-Bourboulis Antimicrobial Agents and Chemotherapy 2016 May 23;60(6):3640-6 DOI: 10.1128/AAC.02974-15View article 🡇 Funding The study was funded by the Hellenic Institute for the Study of Sepsis. Keywords: pneumonia; sepsis

Go to Top